Clinical Trial Update: Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating switching virologically suppressed adults with HIV-1 from their current ART regimen to a fixed-dose combination of dolutegravir/lamiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir/Lamivudine (dolutegravir/lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2022-07-01